Tuning the Reactivity of Osmium(II) and Ruthenium(II) Arene Complexes Under Physiological Conditions
Overview
Authors
Affiliations
The Os(II) arene ethylenediamine (en) complexes [(eta(6)-biphenyl)Os(en)Cl][Z], Z = BPh(4) (4) and BF(4) (5), are inactive toward A2780 ovarian cancer cells despite 4 being isostructural with an active Ru(II) analogue, 4R. Hydrolysis of 5 occurred 40 times more slowly than 4R. The aqua adduct 5A has a low pK(a) (6.3) compared to that of [(eta(6)-biphenyl)Ru(en)(OH(2))](2+) (7.7) and is therefore largely in the hydroxo form at physiological pH. The rate and extent of reaction of 5 with 9-ethylguanine were also less than those of 4R. We replaced the neutral en ligand by anionic acetylacetonate (acac). The complexes [(eta(6)-arene)Os(acac)Cl], arene = biphenyl (6), benzene (7), and p-cymene (8), adopt piano-stool structures similar to those of the Ru(II) analogues and form weak dimers through intermolecular (arene)C-H...O(acac) H-bonds. Remarkably, these Os(II) acac complexes undergo rapid hydrolysis to produce not only the aqua adduct, [(eta(6)-arene)Os(acac)(OH(2))](+), but also the hydroxo-bridged dimer, [(eta(6)-arene)Os(mu(2)-OH)(3)Os(eta(6)-arene)](+). The pK(a) values for the aqua adducts 6A, 7A, and 8A (7.1, 7.3, and 7.6, respectively) are lower than that for [(eta(6)-p-cymene)Ru(acac)(OH(2))](+) (9.4). Complex 8A rapidly forms adducts with 9-ethylguanine and adenosine, but not with cytidine or thymidine. Despite their reactivity toward nucleobases, complexes 6-8 were inactive toward A549 lung cancer cells. This is attributable to rapid hydrolysis and formation of unreactive hydroxo-bridged dimers which, surprisingly, were the only species present in aqueous solution at biologically relevant concentrations. Hence, the choice of chelating ligand in Os(II) (and Ru(II)) arene complexes can have a dramatic effect on hydrolysis behavior and nucleobase binding and provides a means of tuning the reactivity and the potential for discovery of anticancer complexes.
A Half-Sandwich Os(II) Glucoconjugated NHC Complex as a Modulator of Amyloid Aggregation.
Florio D, Annunziata A, Panzetta V, Netti P, Ruffo F, Marasco D Inorg Chem. 2025; 64(7):3335-3345.
PMID: 39945504 PMC: 11863378. DOI: 10.1021/acs.inorgchem.4c04823.
Tabatabai A, Dehghanian E, Mansouri-Torshizi H J Fluoresc. 2024; .
PMID: 38967860 DOI: 10.1007/s10895-024-03820-8.
Sasaki H, Nakagawa I, Furuta T, Yokoyama S, Morisaki Y, Saito Y Cell Mol Neurobiol. 2024; 44(1):32.
PMID: 38568450 PMC: 10991049. DOI: 10.1007/s10571-024-01464-7.
Woods J, Novorolsky R, Bigham N, Robertson G, Wilson J RSC Chem Biol. 2023; 4(1):84-93.
PMID: 36685255 PMC: 9811523. DOI: 10.1039/d2cb00189f.
Cseh K, Geisler H, Stanojkovska K, Westermayr J, Brunmayr P, Wenisch D Pharmaceutics. 2022; 14(11).
PMID: 36432656 PMC: 9699003. DOI: 10.3390/pharmaceutics14112466.